Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Male infertility, Immotile sperm, and Oligozoospermia. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 1 | Male infertility |
CFAP65 encodes cilia and flagella associated protein 65 (1,925 aa). Plays a role in flagellar formation and sperm motility. Highest expression in Testis (17.6 TPM) and Pituitary (4.1 TPM).
Spermatogenic failure 40 is associated with mutations in the CFAP65 gene on chromosome 2.
CFAP65 is classified as a druggable target with score 0.0.
Genetic testing for CFAP65 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spermatogenic failure 40 has been reported in the published literature.
Phenotype severity distribution: 3 always present features.
No clinical trials have been registered for spermatogenic failure 40.
12 publications have been identified in PubMed for spermatogenic failure 40. Research spans Basic Science / Preclinical (42%), Review / Meta-Analysis (33%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 42% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 7:13 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
4 |
33% |
Testing and diagnosis research | 1 | 8% |
Patient case studies | 1 | 8% |
Disease patterns and progression | 1 | 8% |
Parikesit D (2026). [PMID: 42158581](https://pubmed.ncbi.nlm.nih.gov/42158581/). *F1000Res*. [Epidemiology / Natural History]
Cheng J (2026). [PMID: 41745628](https://pubmed.ncbi.nlm.nih.gov/41745628/). *Metabolites*. [Basic Science / Preclinical]
Alsenousy AHA (2026). [PMID: 41724789](https://pubmed.ncbi.nlm.nih.gov/41724789/). *Sci Rep*. [Basic Science / Preclinical]
Zhou L (2026). [PMID: 41714893](https://pubmed.ncbi.nlm.nih.gov/41714893/). *World J Mens Health*. [Review / Meta-Analysis]
Sharma M (2026). [PMID: 35201719](https://pubmed.ncbi.nlm.nih.gov/35201719/). *Unknown Journal*. [Review / Meta-Analysis]
Babakhanzadeh E (2026). [PMID: 42168344](https://pubmed.ncbi.nlm.nih.gov/42168344/). *Sci Rep*. [Diagnostic / Biomarker]
González-Muñoz S (2025). [PMID: 40499151](https://pubmed.ncbi.nlm.nih.gov/40499151/). *Hum Reprod*. [Basic Science / Preclinical]
Stallmeyer B (2025). [PMID: 39120565](https://pubmed.ncbi.nlm.nih.gov/39120565/). *Andrology*. [Review / Meta-Analysis]
Liu L (2025). [PMID: 41033661](https://pubmed.ncbi.nlm.nih.gov/41033661/). *Hum Reprod*. [Basic Science / Preclinical]
Muranishi Y (2024). [PMID: 39318590](https://pubmed.ncbi.nlm.nih.gov/39318590/). *Reprod Med Biol*. [Case Report / Case Series]